Electra Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Electra Therapeutics's estimated annual revenue is currently $2.5M per year.
- Electra Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Electra Therapeutics has 32 Employees.
- Electra Therapeutics grew their employee count by 45% last year.
Electra Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Head Portfolio Management | Reveal Email/Phone |
4 | SVP, Head Technical Operations | Reveal Email/Phone |
5 | Executive Director, Head Corporate Development | Reveal Email/Phone |
6 | Sr Director, HR (Head HR) | Reveal Email/Phone |
7 | Executive Director, Head Portfolio Management | Reveal Email/Phone |
8 | Executive Director, Head Corporate Development | Reveal Email/Phone |
9 | Sr. Director, Corporate Counsel - Head Legal | Reveal Email/Phone |
10 | Lab Manager | Reveal Email/Phone |
Electra Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Electra Therapeutics?
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
keywords:N/AN/A
Total Funding
32
Number of Employees
$2.5M
Revenue (est)
45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 32 | -3% | N/A |
#2 | $6.9M | 32 | 3% | N/A |
#3 | $3.7M | 32 | N/A | N/A |
#4 | $3.7M | 32 | N/A | N/A |
#5 | $3.7M | 32 | N/A | N/A |